Travere Therapeutics Joins American Kidney Fund's 2023 Corporate Membership Program at ... | Region
ROCKVILLE, Md., Sept. 08, 2023 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced that Travere Therapeutics has joined the 2023 class in AKF’s Corporate Membership Program as a
Source: eagletribune.com